|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,373.50 INR | +0.03% |
|
+1.43% | -2.42% |
| 06-02 | Alkem Laboratories Shows Strong Moves But Weak Follow-Through |  |
| 05-29 | Bob Capital Markets Downgrades Alkem Laboratories to Sell From Hold; Price Target is INR4,638 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 6.81B | |||||
| 980B | |||||
| 550B | |||||
| 382B | |||||
| 316B | |||||
| 272B |
Select your edition
All financial news and data tailored to specific country editions
